Adaptive Biotechnologies Corp - COM (ADPT)

Historical Portfolio Holders from Q3 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
141 M
Holdings value Q1 2024
$453 M
Value change Q1 2024
-$10.6 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
178
Number of buys Q1 2024
80
Number of sells Q1 2024
-99
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
00650F109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 141 M $453 M -$10.6 M $3.21 178
2023 Q4 142 M $697 M -$7.29 M $4.90 188
2023 Q3 139 M $759 M +$15.5 M $5.45 181
2023 Q2 136 M $911 M +$14.8 M $6.71 202
2023 Q1 133 M $1.17 B +$16.7 M $8.83 216
2022 Q4 132 M $1.01 B +$16.3 M $7.64 210
2022 Q3 130 M $925 M -$29.7 M $7.12 196
2022 Q2 123 M $994 M +$16.4 M $8.09 186
2022 Q1 125 M $1.74 B -$39.5 M $13.88 200
2021 Q4 123 M $3.46 B +$140 M $28.06 203
2021 Q3 118 M $4 B -$423 K $33.99 210
2021 Q2 117 M $4.79 B +$143 M $40.86 223
2021 Q1 114 M $4.58 B -$120 M $40.26 237
2020 Q4 114 M $6.74 B +$154 M $59.13 239
2020 Q3 111 M $5.4 B +$508 M $48.63 199
2020 Q2 99.8 M $4.83 B +$200 M $48.38 186
2020 Q1 95.9 M $2.66 B +$278 M $27.78 139
2019 Q4 86 M $2.57 B +$148 M $29.92 125
2019 Q3 81 M $2.49 B +$38.9 M $30.90 113
2019 Q2 78.1 M $3.73 B +$3.73 B $48.30 108
2016 Q3 235 $10.1 K +$10.1 K $43.05 1